Acute Rejection. Risk Factors, Management and Complications

Description:

This book presents current research in the study of the risk factors, management and complications of acute rejection in transplant patients. Topics include the mechanisms, management and consequences of acute cellular and antibody mediated rejection in solid organ and reconstructive transplantation; donor specific antibody mediated humoral rejection and biological implications of B cells and novel nucleic acid drugs for the prevention of acute cardiac rejection. (Imprint: Nova Biomedical)

Table of Contents:

Preface

HLA and Non-HLA Genes Polymorphisms: Susceptibility and Severity in Tunisian Patients with Rheumatoid Arthritis;pp. 1-46
(Tarak Dhaouadi, Imen Sfar, Leila Abdelmoula, Henda Krichen, Dorra Khazen, Houda Aouadi, Saloua Jendoubi-Ayed, Taieb Ben Abdallah, Khaled Ayed, Rafik Zouari, Yousr Gorgi, Immunology Research Laboratory in Kidney Transplantation and Immunopathology (LR03SP01), University Tunis El Manar, Charles Nicolle Hospital, Tunisia, and others)

Mechanisms, Management and Consequences of Acute Cellular and Antibody Mediated Rejection in Solid Organ and Reconstructive Transplantation;pp. 47-82
(A. Weißenbacher, T. Hautz, B. Kern, J. Pratschke, S. Schneeberger, Center of Operative Medicine, Department of Visceral, Transplant and Thoracic Surgery, Innsbruck Medical University, Innsbruck, Austria)

Donor Specific Antibody (DSA) Mediated Humoral Rejection and Biological Implications of B Cells in Human Solid Organ Transplantation;pp. 83-109
(Manuel Muro, Alexandre Bosch, Ruth López-Hernández, Francisco Boix, Manuela López, José A. Campillo, Alfredo Minguela, Rocío Álvarez-López, Immunology Service, University Hospital Virgen Arrixaca, Murcia, Spain)

Acute Cellular Rejection: Diagnosis and Immune Mechanisms;pp. 111-130
(Erika Lamkowski Naka, Alvaro Pacheco e Silva Filho, Niels Olsen Saraiva Camara, Federal University of São Paulo (UNIFESP), Brazil)

Presentation, Diagnosis and Treatment of Acute Rejection;pp. 131-149
(Karen L. Hardinger, Daniel C. Brennan, Department of Pharmacy Practice and Administration, School of Pharmacy, University of Missouri-Kansas City, Missouri, USA, and others)

Novel Nucleic Acid Drugs for Prevention of Acute Cardiac Rejection;pp. 151-159
(Jun-ichi Suzuki, Mitsuaki Isobe, Ryuichi Morishita, Ryozo Nagai, Department of Advanced Clinical Science and Therapeutics, University of Tokyo, Japan, and others)

Study of Proliferation Response of the HLA-DQB1 0302 Molecule Associated to Acute Rejection Development in Liver Transplant and Soluble HLA Class I Depletion;pp. 161-184
(Manuel Muro, Luis Marin, Rosa Moya, Alfredo Minguela and Rocío Álvarez-López, Immunology Service, University Hospital Virgen Arrixaca, Murcia, Spain)*

Index